博雅生物：完成转让江西博雅欣和制药有限公司80%股权

Core Viewpoint - The company has signed a contract to transfer 80% of its stake in Jiangxi Boya Xinha Pharmaceutical Co., Ltd. to Fuzhou High-tech Zone Financial Investment Group Co., Ltd. [1] Group 1 - The transfer was formalized through the "Shanghai Property Rights Transaction Contract" [1] - As of September 8, 2025, the relevant industrial and commercial change registration procedures have been completed [1] - After the transfer, the company will hold a 10.6869% stake in Boya Xinha, while its wholly-owned subsidiary, Jiangxi Boya Pharmaceutical Investment Co., Ltd., will hold a 9.3131% stake [1] Group 2 - Following the completion of the transfer, Boya Xinha will no longer be included in the company's consolidated financial statements [1]